Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_110_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
22 Мб
Скачать

fo
https://t.me/med1917
410
Clinical Manifestations
The paralysis affects the side of the face where the anes­thetic was injected (ipsilateral), with the following manifestations:
Eye: owing to involvement of the temporal branch of the
facial nerve.
A strange sensation such as numbness may initially be
noted in the eye (Cooley and Coon1978).
Difficulty closing the eye. The most important sign
(Figure22.3).
Occasional tearing or, on the contrary, hyposecretion
(Genthon etal.1987).
Bell’s sign, when the patient closes eye, the eye globe
turns upwards and there is slight movement of upper eyelid (García-
Rapid, uncontrolled, and repetitive horizontal (side to
Fernández1969; Bernsen1993).
side) or vertical (up and down) movements may rarely be observed in both eyes (nystagmus). Nystagmus is caused by a central nervous system effect (Parsons­Smith and Roberts1970).
Face: owing to involvement of the zygomatic branch of
the facial nerve.
A strange sensation such as numbness may initially be
noted on the face (Cooley and Coon1978).
Disappearance of the nasolabial fold and flattening of
the face with disappearance of the physiognomic traits (García-
Fernández1969) (Figure22.3).
Deviation of the commissure to the healthy side of the
face owing to the predominance of the muscles on this side (García-
The sign is even more noticeable when the patient
Fernández1969) (Figure22.3).
tries to force a gesture such as laughing, speaking, or blowing (the paralyzed cheek is inflated). (Bernsen 1993); when the patient wrinkles his/her brow, no lines are seen on the affected side.
Other less common manifestations include the following: Altered sense of taste (Droter 1959; García-
Fernández1969; Genthon etal.1987; Bernsen1993).
Altered hearing (Tiwari and Keane 1970; Genthon
etal.1987), noises and ringing (tinnitus) (Droter1959), and even ear pain (Stoy and Gregg 1951; García­Fernández1969; Genthon etal.1987; Bernsen1993).
The auriculotemporal nerve may occasionally be anes-
thetized, with the result that the skin around the ear and temporal region is also anesthetized (Stoy and Gregg1951; García-
Although very rare, vertigo and dizziness resulting
Fernández1969).
from central nervous system involvement have been reported (Droter 1959; Parsons-Smith and Roberts 1970).
Facial Palsy Associated withMandibular Block
Facial palsy is generally associated with mandibular block, and, although uncommon, it is thought to occur in 1in 200mandibular block procedures (Table22.14). There are two forms of presentation.
Immediate Onset andShort Duration
This is the most common situation by far in clinical practice. The paralysis is observed immediately or within
minutes following the injection and lasts from minutes to
5 a fewhours (generally 30
minutes to 2 hours, rarely 7 hours) (Table22.15). The clinical manifestations are partial and slight, since the facial nerve is for motor supply and local
Inhability
to close eye
Nasolabial
ld disappear
trend
Asymmetry
of mouth
Figure22.3 Inability to close eye and Bell’s sign. Trend to
disappearance of the nasolabial fold, and deviation of the commissure with asymmetry of mouth.
anesthetics affect motor nerves to a lesser extent than sen­sory nerves. For the same reason, facial palsy disappears
Table22.14 Occurrence offacial paralysis after mandibular
block.
Sample size
Reference Percentage
Kaufman etal. (2000) 1.1% 1/179 Keetley and Moles (2001) 0.3% 2/580 Nooh and Abdullah (2010) 0.02% 1/5000
0.45% 1/200
(cases/total)
t.me/Dr_Mouayyad_AlbtousH
Table22.15 Clinical cases withfacial paralysis after mandibular block.
https://t.me/med1917
Facial Palsy 411
Patient
Reference Age Sex Onset Duration
1. Immediate paralysis of short duration
Droter (1959) 24 Left 2 Haugen (1966) 38 Left <5 Haugen (1966) 28 Left <5 Gray (1978) 44 Left 3 Gray (1978) 29 Left 3 Gray (1978) 16 Left 2 Cooley and Coon (1978) 18 Right 5 Cooley and Coon (1978) 22 Left 5 Cooley and Coon (1978) 30 Right <5
2. Late- onset paralysis of long duration
Stoy and Gregg (1951) 45 Left >Minutes 6 Parsons­Tiwari and Keane (1970) ? Left Hours 5.5 Ling (1985) 22 Left 13 Shuaib and Lee (1990) Shuaib and Lee (1990) Tzermpos etal. (2012) 20 Left 24
a
The same patient on two different occasions.
Smith and Roberts (1970) 25 Left 1 h 3 weeks
a
a
26 Left 24 h 2 weeks 26 Right 24 h 2 weeks
Side of block
Time
min 3.5 h
min 50 min
min 40 min min 2 h min 7 h min 1.5 h min 25 min min 1.5 h
min 1 h
weeks
weeks
days 4 weeks
h 8 weeks
before the effect of the anesthesia on the lower lip (Cooley and Coon1978).
The paralysis is caused by anesthesia of the facial nerve or any of its main branches because the needle is inserted too deep or posterior, potentially leading to injection of the anesthetic into the parotid gland, with the needle trapped in the capsule, thus numbing the facial nerve on its path (Figure 3.14, Chapter 3) (Sicher 1950; García­Fernández1969; Petersen1971; Cooley and Coon 1978). Occasionally, the facial nerve follows an anomalous course and remains in the retromandibular space, thus leaving it more exposed to the anesthetic solution (Sicher 1950; García- Fernández1969; Gray1978).
The dentist can manage this situation as follows: (i) informing the patient, to reassure him/her, that the effect only lasts as long as the anesthetic; (ii) protecting the eye from desiccation of the ocular surface (risk of erosion and ulceration) by closing it with the fingers and placing a damp gauze for the duration of the paralysis.
Late Onset andLong Duration
This situation is extremely uncommon in clinical practice. The paralysis appears late (hours or days) after injection
and generally lasts 2–8 weeks (Table 22.15). The causes are not well known, although the following have been proposed:
1) Abnormality of the facial nerve resulting from delayed
reflex vasospasm caused by the epinephrine in the local anesthetic solution or mechanical irritation by the tip of the needle in the external carotid plexus (Figure 3.14, Chapter3), which communicates with the stylomastoid artery to produce vasoconstriction in the vasa nervorum of the facial nerve, leading to ischemic neuritis (Stoy and Gregg1951; Tiwari and Keane 1970; Gray 1978; Ling 1985). The duration of the paralysis depends on the degree of ischemia and nerve damage (Tiwari and Keane1970).
2) Paralysis resulting from a latent viral infection (Shuaib
and Lee1990) or a previous neurological disorder trig­gered and revealed by the mandibular block (Parsons­Smith and Roberts1970).
The dentist can manage these situations as follows: (i) reassuring the patient because most cases resolve sponta­neously, although it may take weeks; (ii) protecting the eye from desiccation (risk of erosion and ulceration) by closing
t.me/Dr_Mouayyad_AlbtousH

https://t.me/med1917
412
it with the fingers and placing a damp gauze over it at night and wearing dark glasses during the day, and referring the patient to a opthalmologist; (iii) referring the patient to a neurologist with a full report so that the patient can receive an exhaustive neurology work-
up and treatment (Tzermpos etal.2012). In these cases, the neurologist often adminis­ters corticosteroids (Parsons-
Smith and Roberts 1970;
Tiwari and Keane1970; Ling1985; Shuaib and Lee1990).
Facial Palsy Associated withMaxillary Infiltration
The very few case reports of facial palsy associated with maxillary injection are all of late onset (24–72
hours) and long duration (one to several weeks) (Genthon etal.1987; Bernsen 1993). Although the causes are unknown, two explanations can be postulated:
1) Retrograde injection of the anesthetic solution (with
vasoconstrictor), which runs to the posterior superior alveolar artery and thereby to the middle meningeal artery until it reaches the vasa of the facial nerve through the petrous branches and causes ischemic neuritis.
2) Immunoallergy (Bernsen 1993), but with poor quality
of evidence.
The dentist can manage these situations in the same way as for cases of late onset and long duration after mandibu­lar block. Both situations are quite unusual in clinical practice.
Ocular Complications
Ophthalmological complications are rare after dental local anesthesia. Some authors estimate that they affect 1 in 1000 patients who receive injections of anesthetic (Steenen etal. 2012); however, we estimate that this figure is less frequent, and, as indicated in Table22.16, it could be closer to one in every 2000 patients.
Many of these situations may go unnoticed because vis­ual disorders affecting a single eye are not very intense and may even be asymptomatic for the patient since they are compensated by the healthy eye (Blaxter and Britten1967; Leopard1971).
We assessed this problem by reviewing 110 cases pub­lished in the international literature between 1936 and 2019 (Annex 36). Ages ranged from 4 to 73 years, with a mean of 33 years (Peñarrocha- Diago and Sanchis­Bielsa 2000; Rishiraj et al.2005). Females accounted for 70% of cases and males 30% (Annex 36), which is consist­ent with the fact that more women than men attend clinics (Annex 1). In addition, children aged 4–16 years account
Table22.16 Frequency ofocular complications after injection
oflocal dental anesthesia.
Sample
Reference
Bartlett (1972) 3727 1 1:3727 Hidding and Khoury (1991) 1518 2 1:759 Peñarrocha-
Sanchis­Kaufman etal. (2000) 179 3 1:60 Malamed etal. (2001) 1325 1 1:1325 Nooh and Abdullah (2010) 5000 2 1:2500
Diago and
Bielsa (2000)
size Cases Proportion
000 14 1:3571
50
Average 1:1990
Rounded average 1:2000
for over 10% of patients, and in this case the proportion of males and females is similar (50%) (Annex 36). It must benoted that the data obtained from these series may be biased as only the most dramatic cases are published.
Anesthetic Techniques Involved
Although ocular complications can occur with any dental local anesthetic (Marinho 1995), they have a higher inci­dence in the following cases (Annex 36):
Injections into the maxillary arch (this accounts for close
to half of all cases), both through buccal infiltration (most through infiltrations in posterior teeth, mainly molars) and through transpalatal techniques, high tuber­osity techniques, and techniques involving infraorbital nerve block. Ocular complications are even more fre­quent with the latter three techniques (Chapter14).
Mandibular block accounts more than 50% of cases, and
not only with the conventional or direct technique, but also with the Gow- Gates technique (Norris 1982; Fish etal.1989; Dryden1993).
Clinical Manifestations
Most clinical manifestations affect the eye on the side of the injection (ipsilateral), although the contralateral eye may be involved in some cases. This indicates a poor prog­nosis and will be commented on below. Thus, we can describe the following complications (Annex 36):
Visual disorders in over 80% of patients: Double vision (diplopia) in approximately 60%. Impairment of vision, with blurred vision or loss of
visual acuity in 20%.
Blindness (amaurosis) in 20%.
t.me/Dr_Mouayyad_AlbtousH
Ocular Complications 413
https://t.me/med1917
Pupillary disorders in 30% of cases, with dilation of the
pupil (mydriasis) in more than two-
thirds (Figure22.4) and, much less frequently, with contraction of the pupil (miosis).
Eye disorders: Drooping of the upper eyelid (ptosis) in 30%. Periorbital and/or orbital sensation ranging from
numbness to burning sensation or even pain in 15%.
Orbital and/or periorbital blanching in 10%. Other much less frequent disorders include the
following:
Rapid, uncontrolled, and repetitive horizontal (side
to side) or vertical (up and down) movements observed in both eyes (nystagmus).
Posterior displacement of the eyeball within the
orbit (enophthalmos).
Eye examination: Partial paralysis due to inability to move the eye in a
particular direction or complete paralysis (ophthalmo­plegia) in around 40%:
Inability to move the affected eye outward (away
from the nose), that is, loss of abduction, affecting 30% (Figure22.4).
Other movements, without taking into account loss
of abduction or complete paralysis in 10%.
Deviation in the alignment of the eye in relation to the
other eye (strabismus) in 10% (both convergent and divergent).
Absence of contraction when the pupil is exposed to
light in 10%.
Extraocular manifestations in 30%: Dizziness or sensation of vertigo in 10%, rarely accom-
panied by nausea (Cooley and Cottingham1979).
Facial blanching in 10%. This may occasionally affect
the hard palate (Dryden1993; Wilkie2000). Reddening of the face (flushing) is much rarer.
Facial sensation in 10% of cases, ranging from numb-
ness to burning sensation to pain.
Other less common extraocular manifestations include
the following:
Headache (cephalea).
Speech disorders (dysarthria), hoarse voice
(Campbell et al. 1979), ranging from partial loss (dyslalia) to total loss (aphasia).
Other much less common manifestations such as
fever, headache, nausea, and vomiting usually appear in infections of the cavernous sinus, gener­ally one to several days after the injection (Okamoto etal.2012; Simsek etal.2013).
Other Clinical Aspects ofInterest
Other clinical manifestations and aspects are not frequent, although they are of particular interest (Annex 36):
There are five case reports in which clinical manifesta-
tions appeared only when the patient went to bed (Kronman and Kabani1984) or got up (Goldenberg1990; Magliocca et al. 2006; Yoon and Chussid2012; Verma etal.2013). The reasons for this are unknown, although the manifestations were thought to be due to arterio­venous anastomosis or bone disorders.
There are two case reports where ophthalmological com-
plications occurred in the same patient at different times (Goldberg1978; Williams etal.2011) and one case where the complication occurred on three occasions (Petrelli and Steller1980). The causes involved were bone or ana­tomical disorders and a history of myositis in the exter­nal muscles of the eye.
In children younger than 16 years, more than 90% of
cases are caused by mandibular block, appear after a few minutes (rarely before 2 hours), and last minutes to a few hours. There have been no reports of sequelae, except for one case that lasted 4 days (Hales1970) and was due to maxillary infiltration in the molars.
Onset andDuration
Figure22.4 Affected eye (arrow) with a dilated pupil
(mydriasis) that does not move outward to accompany the healthy eye (loss of abduction).
The onset and duration of complications can be summa­rized as follows (Annex 36):
Onset Around 90% appear between the first few minutes and
1 hour after the injection.
A small percentage appear after 24 hours.
Duration More than 80–90% resolve in a few minutes, although
they may take up to 6 hours.
A small percentage take several days or weeks to resolve. Long- term sequelae may occur in a small percentage
of patients.
t.me/Dr_Mouayyad_AlbtousH

https://t.me/med1917
414
Predictors ofSequelae
Analysis of the cases in Annex 36 revealed a series of indi­cators that serve to guide us with respect to the outcome of ocular complications.
Factors indicative of a favorable outcome: If the complications appear within an hour of the
injection, nearly all patients recovered.
If the complications affect children or adolescents
younger than 16
Factors indicative of a poor outcome: If complications appear after 24 hours, then long- term
years, all patients recovered.
involvement or sequelae are observed in 100% of cases.
If ophthalmological complications appear after an
hour, then sequelae or long-
term complications are
observed in 65% of cases.
If the contralateral eye is the affected eye then seque-
lae or long-
term complications are observed in 60% of
cases. Involvement of the contralateral eye is unusual.
If the complication lasts more than 6 hours, irrespec-
tive of when it started, then sequelae are observed in 50% of cases.
Blindness (amaurosis) is the most common sequela, affecting 50% of cases with poor outcome. Other sequelae include mild paralysis (ophthalmoplegia) or mild drooping of the upper eyelid (ptosis).
Management by theDentist
When faced with such a case, the dentist should act asfollows:
1) Stop treatment and reassure the patient that the event is
usually temporary and resolves without sequelae after a few minutes or hours in most cases.
2) Examine the affected eye.
3) Cover the affected eye for as long as the disorder persists
to protect it and ensure correct vision with the con­tralateral healthy eye, as this compensates for the vis­ual defect.
4) Advise the patient not to drive or use dangerous machin-
ery. The patient should be accompanied home.
5) Call the patient the same day/night in order to deter-
mine his/her status.
6) Refer the patient to an ophthalmologist for an evaluation
of the eye and supervision of the recovery process. The patient should always be given a full report of the event. This is particularly important in cases indicative of a poor outcome.
Pathophysiology ofComplications
mechanisms and causes of these alterations after injection of the anesthetic are not completely clear (Walker etal.2004; Dogan and Dora2005; Rishiraj etal.2005; Huang etal.2013). A more detailed explanation is found in Annex 36. In any case, we propose the following explanations.
Retrograde Arterial Flow
The concept of retrograde arterial flow seems counterintui­tive owing to arterial pressure; however, it seems valid if we consider that the anesthetic solution is injected under pres­sure and that arterial pressure falls during the diastolic phase (Williams et al. 2011). This route of intra-
arterial injection with retrograde flow was demonstrated in invivo experiments with monkeys (Aldrete etal.1977,1978).
Figures 22.5 and 22.6 show the pathway followed by anesthetic from the mouth to the eye. The flow of the anes­thetic solution runs backwards under pressure to the max­illary artery, which, via retrograde flow, enables the anesthetic to reach the orbit along two routes:
The short route, via the middle meningeal artery, which
enters the cranium through the spinous foramen. From
here it joins the ophthalmic artery (by anastomosis)
(Hayreh and Dass1962), which enters the orbit to supply
various structures through its branches. These include
the central retinal artery or the lacrimal artery, which
supplies the lateral rectus muscle and the levator muscle,
or the ciliary artery, which supplies the ciliary ganglion.
The long route, via the external carotid artery up to the
carotid bifurcation, at which point the anesthetic solu-
tion ascends via the internal carotid. From here, it
reaches the ophthalmic artery.
Furthermore, the maxillary artery gives off branches to the infraorbital artery, thus accounting for facial blanch­ing, and the descending palatine artery, which, after cross­ing the greater palatine foramen, becomes the major palatine artery, thus accounting for blanching of the palate (Wilkie2000).
In addition to retrograde arterial flow of local anesthetic, other variants affecting the arteries have been suggested, as follows:
The anesthetic solution reaches the orbit via a vascular
abnormality of the alveolar arteries or the middle menin-
geal artery (Blaxter and Britten1967; Goldenberg 1990;
Koumoura and Papageorgiou2001; Uckan etal.2006).
On entering the artery, the needle causes a thrombus
that, by retrograde arterial flow, reaches the orbit and
retina and leads to permanent blindness (Tomazzoli-
Gerosa etal.1988).
Table 22.17 summarizes the main complications and the structures of the eye involved and mechanisms proposed (Von Arx et al. 2014). It should be noted that the exact
Retrograde Venous Flow
The case of retrograde venous flow is more obvious, given that there is no arterial pressure and the veins of the head
t.me/Dr_Mouayyad_AlbtousH
Ocular Complications 415
https://t.me/med1917
Table22.17 Main ocular complications andthe structures ofthe affected eye, aswell aspathophysiology andmechanism
ofproduction.
Ophthalmic complications Anatomical structure involved Mechanism and pathophysiology
Diplopia (double vision) External muscles of the eye (especially the
Amaurosis (blindness) Optic nerve (CN II)
Accommodation disorder (blurred vision)
Mydriasis (dilated pupil) Pupillary sphincter muscle
Miosis (constricted pupila) Pupillary dilator muscle
Ptosis (drooping upper eyelid) Elevator muscle of the upper eyelid
Periorbital ischemia (ischemic blanching around the eye)
Ophthalmoplegia (paralysis of the eye)
Nystagmus Vestibulocochlear nerve (VIII cranial nerve)
Enophthalmos (posterior displacement)
lateral rectus) Oculomotor nerve (CN III) Trochlear nerve (CN IV) Abducens nerve (CN VI)
Retina
Lens Ciliary muscle Parasympathetic fibers of the ciliary ganglion
and of the oculomotor nerve (CN III)
Parasympathetic fibers of the stellate ganglion and oculomotor nerve (CN III)
Parasympathetic fibers of the stellate and ciliary ganglion
Oculomotor nerve (CN III) Superior tarsal muscle Sympathetic fibers of the ciliar ganglion and
stellate ganglion Infraorbital artery
Zygomaticofacial artery Superior labial artery Posterior superior alveolar artery Greater palatine artery Sympathetic fibers
All muscles involved in eye movement Oculomotor nerve (CN III) Trochlear nerve (CN IV) Abducens nerve (CN VI)
External muscles of the eye Orbital muscle
Sympathetic fibers of the stellate and ciliary ganglion
1) Block of the motor nerves of the eye
(oculomotor, trochlear, abducens)
2) Block or ischemia of the muscles of the
eye
1) Block of the optic nerve or the retina
2) Vasospasm of the ophthalmic artery or
the central retinal artery
1) Block of the parasympathetic fibers of the
oculomotor nerve and ciliary ganglion
2) Block or ischemia of the ciliary muscle
1) Block of the parasympathetic fibers of the
oculomotor nerve and stellate ganglion
2) Block or ischemia of the papillary
sphincter muscle
Block of the parasympathetic fibers (Horner-
Oculomotor nerve block Elevator muscle of the eyelid block or
ischemia Sympathetic fiber block Superior tarsal muscle block or ischemia
Stimulation of sympathetic fibers
Oculomotor, trochlear, and abducens nerve block
Eye muscle block or ischemia
Vestibulocochlear nerve block
Sympathetic fiber block (Horner­syndrome)
like syndrome)
like
Source: Table modified from Von Arx etal. (2014).
and neck lack valves, therefore there is no mechanism to prevent the retrograde flow of blood. Furthermore, the veins are more numerous and anatomically more variable than the arteries and their walls are easily penetrated by the needle. Figure 22.7 shows the path followed by the anesthetic solution from the mouth to the eye.
The cavernous sinus warrants a separate comment. This large group of fine- walled veins is located in the middle cranial fossa, on both sides of the sella turcica of the
sphenoid. The anesthetic solution that reaches it can affect the eye through various pathways:
Within the cavernous sinus, along the central part, lie
the internal carotid artery and the abducens nerve (CN VI), which at this level are very vulnerable to the action of the anesthetic owing to the fine walls that separate them (Walker et al.2004; Magliocca et al.2006). This area is also home to the oculomotor nerve (CN III), the
t.me/Dr_Mouayyad_AlbtousH

MOUTH
ORBIT
ry
ry
meningeal ar
ORBIT
https://t.me/med1917
416
Central retinal artery
Ciliary artery
Lacrimal artery
Ophthalmic artery
Superior orbital fissure
Superior ophthalmic vein
Ophthalmic vein
Internal carotid artery
Middle meningeal artery
External carotid artery
Maxillary artery
Maxillary artery
Superior alveolar artery
(descending loop)
Inferior alveolar artery
Figure22.5 Schematic representation of the arterial
retrograde pathway from the mouth to the eye.
Inferior orbital fissureCavernous sinus
Foramen ovale
Foramen lacerum
Foramen venosum
Pterygoid venous plexus
MOUTH
Lower branches of the pterygoid venous plexus
Superior alveolar veins
Inferior alveolar veins
Figure22.7 Schematic representation of the venous retrograde
pathway from the mouth to the eye.
Ophthalmic artery
Middle
tery
Maxillary artery
Internal
carotid artery
External carotid artery
Ciliary artery
Anastomosis
Superior alveolar arte
Inferior alveolar arte
Figure22.6 Arterial retrograde pathway of the local anesthetic solution from the mouth to the eye.  Redrawn from
Rood (1972).
t.me/Dr_Mouayyad_AlbtousH
Ocular Complications 417
)
Abducens ner
https://t.me/med1917
trochlear nerve (CN IV), and the ophthalmic and maxil-
lary nerves (CN V
and CN V2, respectively), although
1
the latter are in contact with the external wall of the cav-
ernous sinus (dura mater), which is thicker and more
difficult for the anesthetic solution to cross (Figure22.8).
In addition, the superior ophthalmic vein drains into the
cavernous sinus via the superior orbital fissure. The
anesthetic solution can flow along this pathway by reflux
to the orbit.
In addition to filling with anesthetic and vasoconstrictor, the cavernous sinus may also become infected by bacteria from the mouth that enter via a contaminated needle (Okamoto etal.2012) and then inflamed (thrombophlebi­tis), thus leading to Tolosa­etal.2013), which usually appears after 24
Hunt syndrome (Simsek
hours or several days and is accompanied by periorbital pain, greater or lesser eye paralysis (ophthalmoplegia), and general involvement with headache, fever, nausea, and vomiting. This complication may take weeks or months to resolve after medical treatment.
Passive Diffusion tothe Orbit
It is difficult for the anesthetic solution to reach the orbit by diffusion (Steenen et al. 2012); however, maxillary buccal infiltrations in the area of the molars, the tech­nique for blocking the posterior superior alveolar nerve (Holmgreen etal.1979; Peñarrocha- Diago and Sanchis­Bielsa 2000; Koumoura and Papageorgiou 2001; Horowitz etal. 2005; Magliocca et al.2006), the high tuberosity technique (Collon1946; Forloine etal.2010), and the transpalatal technique (Dickson and Coates1945;
Saborido 1977; Mercuri1979) may enable diffusion to the orbit via two pathways:
In the posterior part of the maxilla, in the area of the
tuberosity, the solution can spread to the pterygopalatine fossa and, at its highest part, may enter the orbit via the inferior orbital fissure. This is the most frequent pathway.
Via anatomical abnormalities or defects (Magliocca
etal.2006; Williams etal.2011) such as an altered wall in the maxillary sinus (Petrelli and Steller1980) or by vascu­lar or lymphatic defects or defects of the connective tissue (Boynes etal.2010). This pathway is extremely unusual.
Once the solution enters the orbit, it is distributed via intraorbital fat and various fascia, thus leaving some of the organs at the apex of the orbit more vulnerable, as is the case of the abducens nerve (CN VI) and the lateral rectus muscle (Peñarrocha-
Diago and Sanchis- Bielsa 2000; Steenen et al.2012), and favoring onset of double vision (diplopia) and abduction deficit.
Irritation ofthe Sympathetic System
Irritation of the sympathetic system occurs because the tip of the needle can injure the superior or inferior alveolar artery and irritate the sympathetic plexus that surrounds them. This irritation spreads throughout the vascular wall to the maxillary artery until it reaches the sympathetic plexus of the internal carotid artery, from where it reaches the peripheral branches (Kronman and Kabani1984). It then reaches the orbit by the ophthalmic artery, causing ischemia by vasospasm in some of the tissues and organs it supplies (Horowitz etal. 2005), which generally leads to
Sella turcica
Cavernous sinus
Internal carotid
Sphenoid sinus
Nasal cavity
Figure22.8 Schematic representation of a cross- section (coronal plane) of the cavernous sinus, in the middle cranial fossa, and its
association with the cranial nerves and the internal carotid artery.  Redrawn with modifications from Koumoura and Papageorgiou (2001) and Pragasm and Managutti (2011).
artery
ve (VI)
Oculomotor nerve (III)
Trochlear nerve (IV)
Ophthalmic nerve (V
Maxillary nerve (V2)
Dura mater
Greater wing of sphenoid
t.me/Dr_Mouayyad_AlbtousH
1

https://t.me/med1917
418
blanching (Uckan et al. 2006) and other complications (Steenen etal.2012). In one case of mandibular block, the needle did not touch the bone and led to an electric shock sensation in the lower lip, on touching the nerve stem of the inferior alveolar nerve (Wilkie2000).
Sympathetic System Block (Horner- like Syndrome)
Sympathetic system block is the opposite of the previous situation: instead of irritation of the sympathetic system, the anesthetic solution induces selective block of the sym­pathetic fibers.
The most typical manifestations in these cases are
Horner-
like syndrome with contraction of the pupil (mio­sis), vasodilation of the vessels of the face (flushing), and posterior displacement of the eyeball in the orbit (enoph­thalmos). Other typical manifestations of this syndrome, although not exclusive to sympathetic block and that can be caused by other factors (see above), include drooping of the upper eyelid (ptosis), tearing, and, more rarely, dizzi­ness or alterations of the voice.
The mechanisms proposed to explain this selective block
of the sympathetic fibers are as follows:
1) Stellate ganglion block. In mandibular block, the solu-
tion descends via the neck to the pterygomandibular space by the lateral wall of the pharynx (parapharyn­geal space) before passing the paravertebral space and reaching the stellate ganglion via the alar fascia (Campbell etal.1979). Some authors consider this pos­sibility highly unlikely because of the distance between the injection site and the stellate ganglion (Peñarrocha­Diago and Sanchis- Bielsa2000).
2) The anesthetic solution reaches the sympathetic plexus
of the internal carotid artery (Dodds 1956). This is at some distance and thus less likely.
3) The sympathetic fibers that accompany the internal
carotid artery are blocked selectively when this is inside the cavernous sinus (Walker et al. 2004; Dogan and Dora2005).
4) The sympathetic fibers are only blocked in the ciliary
ganglion within the orbit (Peñarrocha- Diago and Sanchis- Bielsa2000).
5) Compression and/or traction of the sympathetic fibers
due to the prolonged position of the neck and head of the dental chair (Ostergaard and Faix2001). However, this explanation seems somewhat unlikely.
Other Proposed Causes
Other causes have been proposed to explain special situa­tions. Although some are very unlikely, others are interesting, for example, hysteria in a 10- year- old girl (Clarke and Clarke
1987), immune response to mepivacaine (Goldberg1978),
vasospasm at the level of the vertebrobasilar vessels lead­ing to contralateral involvement (Machado etal.1999), or revelation of underlying multiple sclerosis that mani­fests with alterations in the contralateral eye (Kocer etal.2009).
Needle- induced Infection
The needle of the syringe can introduce bacteria into deep tissues and thus cause infection. Infections are now very rare thanks to modern disposable needle systems and ster­ile cartridges that are ready for use. Infection can arise from several sources (Connor and Edelson1988):
1) Contamination by the injection equipment itself (nee-
dle, cartridge, syringe). This possibility is remote, since the material is sterile before use.
2) Contamination of the tip of the needle through acciden-
tal contact with microorganisms on the skin or hair before injection.
3) Contamination through the patient’s own flora. This risk
is real, since it is impossible to maintain the oral cavity sterile, although it can be reduced by applying topical antiseptic before injecting the needle. Most published studies on post- anesthesia infections confirm infection of the oral cavity by saprophytes (Popowich and Brooke 1979; Connor and Edelson1988; Kitay etal.1991).
Clinical Manifestations
The first manifestations appear after 8–10 hours (Popowich and Brooke1979; Connor and Edelson1988) or during the first 2–3 days (Cohen and Quinn 1988; Kitay et al.1991), with localized pain and inflammation.
Fever appears in more advanced phases and may worsen with general malaise, chills, and vomiting (Popowich and Brooke 1979; Cohen and Quinn 1988; Connor and Edelson 1988), local inflamed lymph nodes (adenopathy) (Popowich and Brooke1979; Cohen and Quinn 1988), and difficulty swallowing (dysphagia) if the infection reaches the pterygomandibular space after mandibular block. Examination of the area may reveal a fluctuant abscess at the injection site. If the infection is not addressed, advances, or if complications arise, then the following may be observed:
Trismus, with pain on forced opening (Cohen and
Quinn1988; Kitay etal.1991).
Paresthesia of the mental nerve (Barnard1976).
Cellulitis of the neighboring skin due to extension to
thesoft tissue (Popowich and Brooke1979).
Osteomyelitis due to extension to bone tissue
(Barnard1976).
t.me/Dr_Mouayyad_AlbtousH
   419
https://t.me/med1917
Management by theDentist
Initial management includes the following (Popowich
and Brooke 1979; Connor and Edelson 1988; Kitay etal.1991):
Antibiotics, which act mainly against anaerobic flora,
such as amoxicillin, tetracyclines, clindamycin, or metronidazole.
Incision and drainage of the fluctuant abscess.
Where the clinical course is not clear, the patient should
be sent to an oral and maxillofacial surgeon for a more
depth examination, including blood culture, com-
in­puted tomography, magnetic resonance, biopsy (cancer screening) (Barnard 1976; Popowich and Brooke1979; Cohen and Quinn1988; Connor and Edelson1988; Kitay etal.1991), and treatment.
Post- injection Mucosal Ulceration
Although rare, necrosis of the mucosa may be observed at the injection site. It usually occurs in the palatal mucosa, where there is less tissue elasticity (Hartenian and Stenger1976) and more rarely in the buccal attached gin­giva (Carroll1980). Curiously, a case of mucosal ulceration was reported in the pterygotemporal depression after man­dibular block (Giunta etal.1975).
Clinical Manifestations
Symptoms appear at 1–4 days after injection and usually last 1–2 characterized by the following:
Proposed Causes
1) Ischemia caused by the vasoconstrictor in the anes-
2) Trophic alteration of the mucosa caused by needle injury
weeks (Allen 1979; Jastak etal. 1995). They are
Loss of mass on the mucosal surface, leading to ulcera-
tion that may be accompanied by a grayish surface (Giunta etal.1975; Hartenian and Stenger1976), which rarely affects the bone and causes a sequestrum that appears on the ulcer some weeks later (Carroll1980).
Pain on palpation and frequent reddening of the borders
of the ulcer (Hartenian and Stenger1976; Carroll1980).
thetic solution or by excessive pressure when the injec­tion is too fast and/or the volume injected too great (Giunta et al. 1975; Hartenian and Stenger 1976; Carroll1980).
or ischemia caused by the factors mentioned above, leading to lack of irrigation and irreparable necrosis (Hartenian and Stenger1976; Jastak etal.1995). In such
cases, the ulcer may last for more than a month (Hartenian and Stenger1976; Carroll1980).
3) Inadvertent injection of anesthetic solution contami-
nated with disinfectant (Hartenian and Stenger 1976; Jastak etal.1995). This is now unlikely since the car­tridges come in blister packs and no longer have to be placed in disinfectant solutions.
Management by theDentist
Management is essentially based on monitoring to
ensure that a scar forms within 1–2
weeks. In cases of discomfort, symptomatic treatment can be administered. The patient should try to avoid brushing the area by applying rinses with a disinfectant such as chlorhexidine and administering analgesics if the procedure is painful.
If the lesion has not healed within a month, the patient
may have a trophic ulcer, in which case a biopsy is neces­sary to screen for cancer and stimulate scarring, as is habitual in trophic ulcers (Giunta etal.1975; Hartenian and Stenger1976).
Breakage ofthe Needle
At the beginning of the twentieth century, dental needles broke easily. Theodor Blum, from NewYork, published 120 cases collected between 1914 and 1931 (Blum1932) show­ing that 90% of breakages were in what was considered to be at the time a fine- gauge needle (23G and 25G) and that there were no differences between the left and right sides. Fortunately, the frequency of needle breakage has decreased for several reasons:
1) New stainless- steel alloys introduced after the Second
World War (Harrison 1948) made needles much more resistant than those that had previously been made of steel, platinum, or platinum-iridium at the start of the twentieth century (Blum1932; Bump and Roche1973).
2) The introduction of disposable needles in 1959 (Dobbs
1965) and the early 1960s (Bedrock et al. 1999; Pogrel
2009). These needles removed the need for reuse and resterilization, processes that weaken the metal (Blum 1932; Fraser-
3) Disuse of the Fischer mandibular block method, or
1- 2- 3 method, by which the needle changes direction within the tissue, thus increasing the risk of breakage (Blum1924). Consequently, 80% of breakages occurred during mandibular block (Blum1932).
The frequency of needle breakage is currently extremely
low, and although no exact figures are available, one author
Moodie 1958; Bump and Roche 1973).
t.me/Dr_Mouayyad_AlbtousH